Stirling Health and Care Village is a health and care facility at Livilands Gate in Stirling, Scotland. It is managed by NHS Forth Valley as well as Stirling and Clackmannanshire's HSCP. It was formerly known as Stirling Community Hospital.

During the past decade, Stirling Royal Infirmary conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stirling Royal Infirmary" #1 sponsor was "Ferring Pharmaceuticals" with 1 trials, followed by "Institute of Cancer Research, United Kingdom" with 1 trials sponsored, "Liz-Anne Lewsley" with 1 trials sponsored, "University of Edinburgh" with 1 trials sponsored and "VITATOPS" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stirling Royal Infirmary" #1 collaborator was "Chief Scientist Office of the Scottish Government" with 1 trials as a collaborator, "Medical Health Research Infrastructure Council, Australia" with 1 trials as a collaborator, "NHS Lothian" with 1 trials as a collaborator, "National Health and Medical Research Council, Australia" with 1 trials as a collaborator and "National Heart Foundation, Australia" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Stirling Royal Infirmary" are "Prostate Cancer" (2 trials), "Anemia" (1 trials), "Blood Transfusion" (1 trials), "Intensive Care" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Stirling Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Stirling Royal Infirmary" are "Other" (3 trials), "Drug" (2 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "laboratory biomarker analysis" (2 trials), "Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placebo" (1 trials), "DNA methylation analysis" (1 trials), "Degarelix" (1 trials) and "Liberal RBC Transfusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stirling Royal Infirmary" are 2 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Stirling Royal Infirmary". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Stirling Royal Infirmary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stirling Royal Infirmary, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".